Home > M&A deals 2022 > Astorg Partners acquires Corden Pharma International GmbH
Divestiture · Life Science · May 2022

Astorg Partners acquires Corden Pharma International GmbH

On May 2, 2022, Astorg Partners acquired Corden Pharma International GmbH, a life science company in Germany, from International Chemical Investors Group.

Deal at a glance

AnnouncedMay 2, 2022 TypeDivestiture TargetCorden Pharma International GmbH Buyer Astorg Partners Seller International Chemical Investors Group SectorLife Science LocationGermany ValueNot disclosed

Target company

Corden Pharma International GmbH
Germany
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Astorg Partners
Private equity firm · 58 deals on record
  • 3rd transaction in life science
  • 1st transaction in Germany
58deals, all time
3in this sector
2022latest

Seller

International Chemical Investors Group
Company · 1 deal on record
1investments
1in this sector
1exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Tubulis GmbHSame sector and country · Apr 2026
STADA Arzneimittel AGSame sector and country · Mar 2026
Tubulis GmbHSame sector and country · Mar 2024

Questions about this deal

Who acquired Corden Pharma International GmbH?Astorg Partners acquired Corden Pharma International GmbH on May 2, 2022.

Who sold Corden Pharma International GmbH?International Chemical Investors Group was the seller.

What type of deal was it?It was a divestiture in the life science sector in 2022.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).